H J Vloedgraven - Concepedia

Author

H J Vloedgraven

Also Known As

H J Vloedgraven, H VLOEDGRAVEN, H Vloedgraven, HANS J.M. VLOEDGRAVEN, HJM Vloedgraven, Hans J.M. Vloedgraven, Hans Vloedgraven

Publications

Citations

H-Index

Concepts

All Affiliations

Leiden University Leiden University Medical Center

About

H J Vloedgraven is an author at Leiden University specializing in medicine, tumor biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	776
2	Cell Biology	3	3	470
3	Health Sciences	2	2	371
4	Biomedical Engineering	1	1	306
5	Gastroenterology	1	1	58

H J Vloedgraven

Publications

Citations

H-Index

Page 1

	Year	Citations
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. Gabri van der Pluijm, H J Vloedgraven, E. van Beek, Journal of Clinical Investigation Biomedical EngineeringOrthopaedic SurgeryOsteoporosisTumor BiologySynthetic Bone Substitute	1996	306
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. S Ganesh, Cornelis F.M. Sier, G Griffioen, PubMed UrologyColorectal Cancer InvasionPlasminogen ActivatorsGastrointestinal OncologyMedicine	1994	161
Monitoring Metastatic Behavior of Human Tumor Cells in Mice with Species-Specific Polymerase Chain Reaction: Elevated Expression of Angiogenesis and Bone Resorption Stimulators by Breast Cancer in Bone Metastases Gabri van der Pluijm, Bianca Sijmons, H J Vloedgraven, Journal of Bone and Mineral Research	2001	123
Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components. van der Pluijm, H J Vloedgraven, Socrates E. Papapoulos, PubMed	1997	103
Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo Gabri van der Pluijm, Bianca Sijmons, H J Vloedgraven, American Journal Of Pathology MedicineCell AdhesionCell TraffickingHuman Breast CancerCell-matrix Interaction	2001	97
Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Gabri van der Pluijm, H J Vloedgraven, B Ivanov, PubMed SclerostinBreast OncologyBone Sialoprotein PeptidesCancer BiologyOsteoporosis	1996	67
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis Cornelis F.M. Sier, H J Vloedgraven, Sjam Ganesh, Gastroenterology UrologyOncologyChemoprevention StrategyGastrointestinal OncologyInhibitor Type 1	1994	65
Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach. Cornelis F.M. Sier, Hein W. Verspaget, G Griffioen, Gut Human Colon CarcinomasUrologyEsophageal CancerPlasminogen ActivatorsGastrointestinal Oncology	1993	58
Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis H J Vloedgraven, G Griffioen, S Ganesh, British Journal of Cancer Plasminogen ActivatorsInhibitor Type 1Familial Adenomatous PolyposisMedicinePathology	1995	22
Role of Integrins in the Attachment of Metastatic Follicular Thyroid Carcinoma Cell Lines to Bone Johannes W. A. Smit, Gabri van der Pluijm, H J Vloedgraven, Thyroid	1998	14

Page 1